Children who are neutropenic and unwell, even if normothermic, should be assumed to have infection and be treated appropriately.

Similar documents
PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

Protocol for the Management of Neutropenic Sepsis in Adult Patients P

Title Management of Fever and Neutropenia (Neutropenic Sepsis) in Paediatric Oncology Patients presenting to NDDH Guidelines. Author s job title

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Antimicrobial Management of Febrile Neutropenic Sepsis

Neutropenic Sepsis Guideline

Guideline for the Management of Acute Chest Syndrome in Children with Sickle Cell Disease

Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway

PILOT STUDY PROPOSAL FOR EARLY DISCHARGE OF LOW-RISK NEUTROPENIC PATIENTS

NEUTROPENIC SEPSIS IN ADULT PATIENTS. Consultant Clinical Oncologist CLINICAL GUIDELINE

Scottish Childrens Cancer MSN CYPC Febrile Neutropenia Guideline December 2013, Version 1

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS

High Intensity Chemotherapy Guidelines for Haematology Patients at ASPH

Protocol for Management of Neutropenic Sepsis in Adult Patients within the First 24 hours of Presentation

Neutropenic Sepsis Acute General Management and Support. Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology

BREAK 11:10-11:

North Derbyshire OPAT (Outpatient Parenteral Antimicrobial Therapy) Pathway for Primary Care (Step-Up Pathway/Admission Avoidance)

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

Wessex Paediatric Oncology Supportive Care Guidelines: Management of Febrile Neutropenia

The Management of Acute Chest Syndrome in Children with Sickle Cell Disease

Trust Guideline for the Management of: Condition or Procedure in Adults and / or Children

The Oxford AHSN Sepsis Pathway

DERBY-BURTON CANCER NETWORK CONTROLLED DOC NO:

Right Iliac Fossa Pain

Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013

StRs and CT doctors in haematology. September Folinic acid dose modified.

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

MANAGEMENT OF DENGUE INFECTION IN ADULTS (Revised 2 nd Edition) QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

Management of common chemotherapy related side effects. Dr Lee-Ann Jones

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Fever in children aged less than 5 years

SOUTH THAMES CHILDREN S CANCER NETWORK GROUP. REFERRAL PROTOCOLS AND DIAGNOSIS AND STAGING PROTOCOLS October 2014

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Obinutuzumab+Bendamustine followed by Obinutuzumab Maintenance Burton in-patient Derby in-patient Burton day-case Derby day-case

Lung Pathway Group Cisplatin & IV Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)

Prescribing Framework for Mycophenolate Mofetil for Immunosuppression in ADULTs

Lung Pathway Group Cisplatin & PO Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)

INFLECTRA Infliximab Infusion 1,2 & 3

Antimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections

PedsCases Podcast Scripts

Cisplatin and Gemcitabine Bladder Cancer: Full and split dose

Antibiotic Protocols for Paediatrics Steve Biko Academic Hospital

MAKING SENSE OF IT ALL AUGUST 17

KEY MESSAGES. There are three phases in dengue infection-febrile phase, critical phase and recovery (reabsorption) phase.

The changing face of

GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT

Sepsis in primary care. what is good care?

SHARED CARE PRESCRIBING GUIDELINE

Clinical Assessment Tool

NECN CHEMOTHERAPY HANDBOOK PROTOCOL

Charlson Comorbidities (please TICK all that apply)

High Dose Cytarabine plus high dose Methotrexate for CNS Lymphoma

NORTH AND EAST DEVON HEALTHCARE COMMUNITY SHARED CARE PRESCRIBING GUIDELINE

Name of Shared Care Agreement: AZATHIOPRINE/6-MERCAPTOPURINE: Oral immunomodulating drugs for inflammatory bowel disease. Reference number: 01/2008

Haemodialysis central venous catheter-related sepsis management guideline Version 3. NAME M. Letheren Chair Clinical Effectiveness Advisory Group

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE

Patient Treatment Date/time: Diagnosis: Treatment Regimen:

MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist?

ALL Phase 2 Induction (25-60 years)

SHARED CARE AGREEMENT: METHOTREXATE S/C

Oxaliplatin and Gemcitabine

Cisplatin Vinorelbine (Oral) therapy +/- radiotherapy

Pharmacy Prior Authorization

PREOPERATIVE ANAEMIA PATHWAY

Seasonal Influenza in Pregnancy and Puerperium Guideline (GL1086)

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

ALL MAINTENANCE (25-60 years)

Pulmonary Embolism Pathway

FOLFIRINOX (Irinotecan, Oxaliplatin & infusional Fluorouracil) Cumbria, Northumberland, Tyne & Wear Area Team

Note: There are other bendamustine protocols, ensure this is the correct one for a given patient.

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Neonatal Sepsis and observation Guideline GL 380

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: AZATHIOPRINE Protocol number: CV 04

Suspected Deep Vein Thrombosis (DVT) Assessment

Standard care plan for Carboplatin and Etoposide Chemotherapy References

Guidelines for the management of urinary tract infections in children 0-17 years

Lung Pathway Group Carboplatin & PO Vinorelbine in Non-Small Cell Lung Cancer (NSCLC)

Have you ever managed patients who have experienced an adverse reaction to transfusion?

Paediatric Directorate

PEMBROLIZUMAB (KEYTRUDA ) for the treatment of advanced melanoma or previously treated NSCLC

DERBY-BURTON LOCAL CANCER NETWORK FILENAME Peruse.DOC CONTROLLED DOC NO: CCPG R29

SHARED CARE GUIDELINE

BEVACIZUMAB (AVASTIN ) & Paclitaxel PROTOCOL

Breast Pathway Group EC x 4 Docetaxel x 4: Epirubicin & Cyclophosphamide followed by Docetaxel in Early Breast Cancer

MATRIX (Methotrexate, Cytarabine, Thiotepa and Rituximab)

R-IDARAM. Dexamethasone is administered as an IV infusion in 100mL sodium chloride 0.9% over 30 minutes.

Standard care plan for 1 st line palliative chemotherapy in advanced non small cell lung cancer References

Azathioprine and Mercaptopurine

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Gemcitabine + Capecitabine (ESPAC-4 Trial)

ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS

PREOPERATIVE ANAEMIA PATHWAY

Staging Sepsis for the Emergency Department: Physician

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016

Definition of high risk disease for diffuse large B-cell lymphoma is score 4 or 5 based on the following risk factors:

Transcription:

PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY Purpose: This document is intended as a guide to the investigation and management of children presenting in Salisbury District Hospital with suspected neutropenic sepsis. For further information please look at the Management of Febrile Neutropenia guideline on: http://www.uhs.nhs.uk/media/suhtextranet/services/paediatriconcology/febrile-neutropenia.pdf Background: Children with cancer are particularly susceptible to life-threatening infections. Chemotherapy affects the body's normal defences against infection by causing marrow depression and in some cases disrupts mucous membranes in the gut & mouth. Central lines and bone marrow sites are a potential focus of infection. The term febrile neutropenia includes patients who are haemodynamically stable with no obvious focus of infection, to those in septic shock. Neutropenic Sepsis is a Medical Emergency, which can be life threatening. Intravenous antibiotics MUST be administered within 60 minutes of arrival to hospital or within 60 minutes of the signs and symptoms developing if the patient is an in patient. It requires prompt assessment and appropriate investigations and commencement of empirical treatment if neutropenia is suspected i.e. do not wait for the low neutrophil count to be confirmed Definition of Febrile Neutropenia Neutrophil count is 0.5 or lower and either Temperature 38C and above on a single occasion or Signs and symptoms consistent with clinically significant infection Fever is usually the first (and may be the only) sign of neutropenic sepsis, but neutropenic sepsis can occur in the absence of fever, especially in patients on corticosteroids or following administration of paracetamol Children with leukaemia are usually neutropenic at presentation Children receiving treatment for ALL are likely to be neutropenic during delayed intensification and consolidation blocks Suspect neutropenia 7-10 days post chemotherapy in children with solid tumours Other symptoms and signs include: Influenza-like symptoms Drowsiness or confusion Hypotension Tachycardia Vomiting Obvious focus of infection (e.g. mouth, chest, urine, diarrhoea) Children who are neutropenic and unwell, even if normothermic, should be assumed to have infection and be treated appropriately. 1

Step 1: History Ask about pain around line site, cough, dyspnoea, abdominal pain, diarrhoea, fluid intake, line flushing. Onset of temperature or rigors and tachycardia within a few hours of having a central line flushed should be considered to be a line infection until proven otherwise. Children receiving chemotherapy that induces mucositis are at risk of Gram negative infections. Step 2: Examination Check line entry & exit site & any recent bone marrow or lumbar puncture sites in addition to normal examination including ENT and perianal area Measure peripheral perfusion, blood pressure, respiratory rate, oxygen saturation if indicated, ongoing fluid losses & urinary output. Hypotension is not necessary for the diagnosis of septic shock Step 3: Investigations Immediate investigations should include Blood cultures Cultures should be taken from each lumen of the central line and appropriately labelled. Peripheral cultures are not routinely done, but there may be specific instances where this is appropriate. (If clinically concerned about anaerobic infection, e.g. with severe mucositis remember to take anaerobic blood cultures.) FBC, U&Es, CRP, LFT, Lactate and blood gas These can be taken from the central line immediately on arrival to hospital, by a trained member of Nursing Staff or Doctor. Antibiotic therapy can then be instigated. Other investigations should include MSU - if under 5 yrs old or urinary symptoms present but - Bacteriology and mycology Swab From skin lesions/central line sites if applicable (look for areas of redness and tenderness: pus not present when neutropenic) Investigations to consider if clinically indicated Stool - MC&S, mycology and virology if diarrhoea CXR LP NPA/sputum/viral throat swab Swabs from sites of clinical infection NB pus usually absent when neutropenic All culture specimens should ideally be done before antibiotics are given but do not delay unnecessarily in giving antibiotics (for example in collecting a urine sample). Management of Pyrexia/Infection Antipyretics can mask fever and should not be used in patients who might be neutropenic. Once there is a clear decision to start antibiotics (e.g. child is on their way to hospital with a fever) then paracetamol may be given. Pain can be managed with oramorph. Ibuprofen should be used with caution in thrombocytopenia as it affects platelet function and must be avoided in patients receiving iv Methotrexate and mifamurtide. For more detailed information please refer to the Wessex Paediatric Oncology Regional Supportive Care Guidelines. 2

Step 4: Treatment The mainstay of treatment of febrile neutropenia is early use of empiric antibiotics, appropriate supportive care and regular review. Most children with febrile neutropenia will appear very well, but still need early treatment with antibiotics as infection could progress rapidly. We no longer determine risk groups to assess antibiotic usage Empirical antibiotic treatment of Febrile Neutropenia in patients who are relatively well Single agent Piperacillin/Tazobactam* Child 1 month-18 years 90 mg/kg (max. 4.5 g) 6 hourly < 1 month 90 mg/kg 8 hourly *unless patient specific or local microbiological indications Empirical antibiotic treatment of febrile neutropenic patients with signs of severe sepsis e.g. poor peripheral perfusion, rigors, altered mental status or hypotension Dual agent Piperacillin/Tazobactam & Gentamicin* Age Piperacillin/Tazobactam Age Gentamicin < 1 month 90 mg/kg 8 hourly > 7days 1month 5 mg/kg od* child 1 month-18 years 90 mg/kg (max 4.5g) 6 hourly child 1 month-18 years 7 mg/kg od* *Trough level before 2nd dose (do not delay administration of 2nd dose by waiting for result unless known renal dysfunction) Specific considerations: Children known to be colonised with resistant bacteria should be started on patient specific antibiotic regimen Penicillin allergy treat with meropenem +/- gentamicin Receiving high does methotrexate Penicillins contraindicated use meropenem Bone tumours with endoprosthesis consider adding teicoplanin if focal signs Patient on cisplatin avoid gentamicin but do not withhold initial dose if septic/unwell Abdominal/perianal infection consider adding metronidazole not usually needed for mucositis See Guideline for further considerations/advice 3

Step 5: Risk Assessment medical team to fill in History Age Are any of these risk factors present? Inpatient at onset of FN Down Syndrome PICU during past FN episode <1 year Initial assessment on admission 48 hour assessment Diagnosis/treatment ALL (except maintenance Infant ALL AML Intensive B-NHL protocols Anaplastic lymphomas Stage 4 neuroblastoma PBSCT pre engraftment Ewing s sarcoma Aplastic Anaemia Clinical features Shock or compensated shock Haemorrhage Dehydration Metabolic instability Altered mental state Pneumonitis Significant mucositis Respiratory distress/compromise Perirectal infection Soft tissue abscess/infection (other than minimal redness around central line site) Rigors Irritability/meningism Compliance with outpatient treatment Organ failure Inability to take oral meds Poor compliance Social/family concerns 48 hours assessment Neuts<0.1 Positive blood cultures Not clinically well If none of the above features are present then patient may be considered Low Risk for conversion to oral antibiotics at 48 hours or stopping antibiotics all together If any risk factors are present at 48 hours the patient is treated as Standard Risk See Wessex Paediatric Oncology Supportive Care Guideline Management of Febrile Neutropenia for further guidance 4

Patient Clerking- Nursing Integrated Care Pathway for the Paediatric Consultant Date and time of admission: Nursing observations: (please complete each area) Temperature: C O 2 saturation: % on air Weight Kg Pulse rate: /min Respiratory rate: /min BP: CALL DOCTOR Doctor MUST be aware that an URGENT response is required- should be seen within 30 minutes Time doctor called: Initial Nursing Assessment Signature 5

Patient Clerking- Nursing Integrated Care Pathway for the Paediatric Intravenous Access: If patient has a central venous catheter/portacath a trained member of staff, if available, should take bloods from the line as indicated below. Available: Yes No Bloods taken: Blood Cultures from each lumen Yes No FBC Yes No U&E/LFT Yes No CRP Yes No G&S Yes No N/A Coagulation Screen Yes No N/A Lactate Yes No Other Investigations: MSU Line swab Stool culture (mc&s/virology) Throat swab If patient not seen by Doctor within 30 minutes of admission, please contact on call Registrar/ Consultant. If any oncology patient is admitted please phone 02381 205778 Leave details of your name, patient name, Salisbury hospital, date of admission and reason for admission Please note this is not for advice. If advice is required phone the Piam Brown clinical team Phone call completed by 6

Patient Clerking Medical Integrated Care Pathway for the Paediatric Time of medical assessment: History: (please complete each area) Presenting symptoms: Underlying condition: Stage of Treatment and Recent Treatment: Medications: Allergies: (including concerns regarding use of Gentamicin or Cisplatin) Previous reaction to Blood products: Yes No if so, which: Most recent blood count: Date: Result: 7

Patient Clerking Medical Integrated Care Pathway for the Paediatric Clinical Examination: (please complete each area) Conscious Level: Mouth: Clean Mucositis Ulcerated Candida Line Site: Clean Inflamed Purulent Tracking CVS: Blood Pressure: Pulse: CRT: Heart Sounds: Respiratory: Respiratory rate: Oxygen Saturations: Abdominal: Perineum: Clean Inflamed Ulcerated LP or bone marrow sites Normal Abnormal Not applicable Other: 8

Patient Clerking Medical Integrated Care Pathway for the Paediatric Investigations: Note: Bloods may have already been taken by nursing staff. FBC Yes No U&E/LFT Yes No CRP Yes No G&S Yes No N/A Coagulation Screen Yes No N/A Lactate Yes No Blood Cultures Central Peripheral (if no central access) Consider MSU Line swab Stool culture (MC&S/virology) CXR Throat swab Doctor s Signature 9

Patient Clerking Medical Integrated Care Pathway for the Paediatric Neutropenic Patient, Salisbury NHS Foundation Management: Details of Emergency Resuscitation if required: Antibiotic Therapy (please tick chosen therapy): Tazocin./kg (Piperacillin and Tazobactam) Gentamicin /kg If signs of severe sepsis see page 3 Penicillin allergy or receiving high dose methotrexate Yes No If yes to either of the above treat with Meropenem (20mg/kg 8 hourly) +/- Gentamicin if required Be aware Gentamicin is contraindicated if patient is about to receive Cisplatin, patient has had Cisplatin in the last 6 weeks, or during high dose Methotrexate treatment & rescue. Caution in renal impairment or if significant risk there of e.g. tumour lysis. Continue Co-trimoxazole prophylaxis if taking. Please record time of antibiotics given: Antibiotic 1: Antibiotic 2 (if applicable) Time first dose administered: (should be within 60 minutes of arrival) Patient Clerking Medical 10

Integrated Care Pathway for the Paediatric Management: Additional Therapy required: Analgesia: Yes No Maintenance fluids: Yes No Blood Products: Yes No Nutrition: Yes No Please inform Middle Grade/ Consultant of admission at appropriate time. Date and Time informed: Senior Review: Patient Clerking Medical Signature 11

Integrated Care Pathway for the Paediatric Results Date Hb WCC Plt Neutrophils Na K Urea Creatinine CRP Alb Protein ALP ALT Bilirubin Ca PO4 Mg Microbiological Results Date sent Culture site Result Organism, Sensitivities and Date Reported 12

Patient Clerking Medical Integrated Care Pathway for the Paediatric Discharge Check List: Standard Discharge letter with TTO s completed: Yes No Piam Brown Discharge (page 15) form completed and faxed: Yes No Date of next blood test arranged: Yes No Date of next Hospital appointment arranged: Yes No Community Nurses informed of admission/discharge: Yes No Dr Staples/Dr Ridley aware of admission/discharge: Yes No 13

Intentionally left blank 14

Paediatric Oncology Patients - Summary of treatment received at POSCU Information that will be useful to us: reason for admission & other problems e.g. febrile neutropenia (inc duration of antibiotics & culture results), nausea, vomiting, need for iv fluids, mucositis & severity, duration of TPN (if applicable) & blood results. Toxicity chart may help with grading (tick appropriate box) Date of admission Weight O/A DOB Date of discharge Weight at discharge Blood counts & transfusions: ensure parent held record up to date with blood counts & dates of transfusions Main Issues (febrile neutropenia, vomiting etc) please list or code as below: - 1. 2. 3. 4. Toxicity 0 1 2 3 4 Oral None Soreness Ulcers/able to eat solids Unable to eat solids TPN due to stomatitis Vomiting (no. episodes/24 h) 0 1 2-5 6-10 >10 or TPN necessary Diarrhoea None Transient 1-2 days Tolerable > 2 days Intolerable Bloody diarrhoea or TPN needed Constipation None Mild Moderate Abdominal distension Distension & vomiting Infection None Minor: oral antibiotics Moderate: well IV antibiotics Major: unwell Unwell & hypotension Fever ( C) None 37.1 38 38.1 40 > 40 for < 24 hr > 40 for > 24 hr Other In addition for febrile neutropenia dates of starting/changing antibiotics & any positive culture results Antibiotic e.g. Date started Date stopped Reason for change Tazocin Microbiology Date Culture results Sensitivities Other issues TPN etc: Drugs on discharge: 15